This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of James J Egan
Introduction
James J Egan is a notable inventor based in Winnetka, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of cardiac conditions. His innovative approach has led to the development of a unique therapeutic method that addresses cardiofibrosis.
Latest Patents
James J Egan holds 1 patent for his invention titled "Method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and epoxymexrenone." This patent describes a therapeutic method for treating cardiofibrosis or cardiac hypertrophy using a combination therapy that includes a therapeutically-effective amount of an angiotensin II receptor antagonist and a therapeutically-effective amount of epoxymexrenone.
Career Highlights
Egan has been associated with G.D. Searle & Company, where he has contributed to various research and development projects. His work has focused on advancing medical treatments and improving patient outcomes in cardiovascular health.
Collaborations
Throughout his career, James has collaborated with several professionals in the field, including Ellen G McMahon and Gillian M Olins. These collaborations have fostered innovation and have been instrumental in the development of his patented methods.
Conclusion
James J Egan's contributions to medical innovation, particularly in the treatment of cardiofibrosis, highlight his role as a significant inventor in the field. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile